Ten63 Therapeutics

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. Ten63 Therapeutics is based in Durham, NC and was founded in 2018. It was valued at $979 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $50.5 million across 1 recorded round; the latest was a $2.1 million seed round in Jan 2021.

PMV mark · valuation
$979.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$50.5M
Last round
Seed Round
Jan 2021
How much has Ten63 Therapeutics raised?
$50.5Macross 1 recorded rounds · Jan 2021 – Jan 2021

Most recently, Ten63 Therapeutics raised $2.1M in its Seed Round (Jan 2021).

Free account
More of Ten63 Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Ten63 Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ten63 Therapeutics round by round

1 rounds
Jan 2021Seed Round$2.1MSEC filing▮
7 investors participated

How much has Ten63 Therapeutics raised?

Ten63 Therapeutics has raised $50.5 million in total; 1 of its rounds is on record. The largest on record was a $2.1 million seed round in Jan 2021.

Ten63 Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2021 ($2.1 million sold to 7 investors).

Ten63 Therapeutics investors

20 investors are on record for Ten63 Therapeutics, including SOSV, Calm Ventures, Draper Associates and K5 Global. By type, the record holds 8 venture capital firms. The seed round in Jan 2021 drew 7 investors.

For fundraisers
Raising for a company like Ten63 Therapeutics?

20 investors have backed Ten63 Therapeutics.

See all 20 investors →

Frequently asked about Ten63 Therapeutics

How much has Ten63 Therapeutics raised?
Ten63 Therapeutics has raised $50.5M in total across 1 recorded funding rounds.
When was Ten63 Therapeutics's last funding round?
Ten63 Therapeutics's most recent recorded round was Seed Round in Jan 2021, raising $2.1M.